Global Contraceptive Pills Market Report and Forecast 2023-2031

The global contraceptive pills market size reached a value of USD 18.66 billion in 2022. The market is further expected to grow at a CAGR of 3.92% during the forecast period of 2023-2031, likely to attain a value of USD 26.35 billion by 2031. The growth of the market is likely to be driven by the rapid technological developments.

Contraceptive Pills Market: Introduction and Overview
Contraceptive pills are medications taken orally by people with a uterus to prevent pregnancy. They contain hormones, typically a combination of oestrogen and progestin, or just progestin alone, that work to prevent ovulation, thicken cervical mucus to prevent sperm from reaching the egg, and thin the lining of the uterus to make it less receptive to implantation. There are many different types and formulations of contraceptive pills available, and they must be prescribed by a healthcare provider. When used correctly and consistently, contraceptive pills are highly effective in preventing pregnancy.

The contraceptive pills market has numerous applications in women's health and family planning. The primary application is to prevent unintended pregnancy, but contraceptive pills are also used to regulate menstrual cycles, manage symptoms of polycystic ovary syndrome (PCOS), treat acne, and alleviate symptoms of endometriosis. Additionally, some types of contraceptive pills can be used for hormone replacement therapy (HRT) in people experiencing menopausal symptoms. Long-term use of contraceptive pills has been associated with a reduced risk of certain cancers, making them an important tool in cancer prevention. With the development of new and improved formulations of contraceptive pills, the potential applications of this market are likely to continue expanding.

Pros of contraceptive pills:

• Highly effective: When taken correctly and consistently, contraceptive pills are up to 99% effective in preventing pregnancy
• Easy to use: Contraceptive pills are easy to use and can be taken at home. They do not require any special equipment or training
• Regulates menstrual cycle: Contraceptive pills can regulate the menstrual cycle and reduce menstrual pain, cramps, and heavy bleeding
• Reduces the risk of some cancers: Studies have shown that long-term use of contraceptive pills can reduce the risk of ovarian and endometrial cancers
• Can improve acne: Some types of contraceptive pills can improve acne by regulating hormones that cause acne

Cons of contraceptive pills:

• Requires daily use: Contraceptive pills must be taken every day at the same time, which can be a challenge for some people
• May cause side effects: Common side effects of contraceptive pills include nausea, headaches, weight gain, and mood changes. Some people may also experience more serious side effects, such as blood clots
• Does not protect against STIs: Contraceptive pills do not protect against sexually transmitted infections (STIs), so additional protection such as condoms may be needed
• May not be suitable for everyone: Some people may not be able to use contraceptive pills due to underlying health conditions or other factors
• Cost: The cost of contraceptive pills can vary depending on the brand and insurance coverage and can be a barrier for some people

It is important to speak with a healthcare provider to determine if contraceptive pills are the best option for you, and to discuss potential risks and benefits.

Contraceptive Pills Market Segmentations

Market Breakup by Type

• Progestin Pills
• Combination Pills
• Monophasic
• Triphasic
• Others

Market Breakup by Drug Type

• Generics
• Branded

Market Breakup by Therapy Type

• Monotherapy
• Combined Contraceptives

Market Breakup by Age Group

• 15-45 Years
• Above 45 Years

Market Breakup by Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Channel
• Public Channel
• Others

Contraceptive Pills Market Breakup by Region

North America

• United States of America
• Canada

Europe

• United Kingdom
• Germany
• France
• Italy
• Others

Asia Pacific

• China
• Japan
• India
• ASEAN
• Australia
• Others

Latin America

• Brazil
• Argentina
• Mexico
• Others

Middle East and Africa

• Saudi Arabia
• United Arab Emirates
• Nigeria
• South Africa
• Others

Contraceptive Pills Market Scenario

The contraceptive pills market has been driven by several key factors, including increasing awareness and acceptance of contraceptives, the rise in the number of sexually active women, and government initiatives to promote family planning. Technological advancements in contraceptive pills have led to the development of new formulations with fewer side effects and higher efficacy rates, further driving demand. Growing female empowerment has also led to a higher demand for contraception, including contraceptive pills. In addition, the increasing incidence of sexually transmitted infections (STIs) has led many women to use contraceptive pills in combination with condoms, driving demand for both products. A trend in the market is the growing popularity of long-acting reversible contraceptives (LARCs) such as intrauterine devices (IUDs) and implants, which provide more long-term contraception and do not require daily use.

Additionally, the availability of over-the-counter emergency contraceptive pills (ECPs) has increased, making them more accessible to those who need them. Overall, the contraceptive pills market is expected to continue growing as more women seek effective and convenient contraception.

Key Players in the Global Contraceptive Pills Market

The report gives an in-depth analysis of the key players involved in the contraceptive pills market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

• Piramal Enterprises Ltd
• Agile Therapeutics
• Johnson & Johnson Services, Inc
• Abbive Inc
• Merck & Co Inc
• Teva Pharmaceuticals Industries Ltd
• Bayer AG
• Pfizer Inc
• Helm AG
• Reckitt Benckiser Group PLC
• Viatris Inc
• Amneal Pharmaceuticals LLC
• Bayer AG
• Allergan plc
• Agile Therapeutics

This product will be delivered within 5-7 business days.